Brief: Gensight Biologics Raises EUR 25 Mln In Oversubscribed Private Placement

Gensight Biologics SA

22/10/2020 05:38

Oct 22 (Reuters) - Gensight Biologics SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS SUCCESSFULLY RAISES €25 MILLION IN AN OVERSUBSCRIBED
PRIVATE
PLACEMENT WITH US AND EUROPEAN INSTITUTIONAL INVESTORS
    * HAS ISSUED 5,954,650 NEW ORDINARY SHARES WITH A NOMINAL VALUE OF EUR 0.025
EACH
( "NEW SHARES"), FOR TOTAL GROSS PROCEEDS OF APPROXIMATELY EUR 25 MILLION BY
MEANS OF AN ACCELERATED BOOKBUILDING PROCESS TO BENEFIT OF CATEGORIES OF PERSONS
    * BOOK WAS OVERSUBSCRIBED, BASED ON DEMAND FROM NEW AND EXISTING INVESTORS
    * ISSUE PRICE OF NEW SHARES IS EUR 4.20 PER SHARE, REPRESENTING A 12.5%
DISCOUNT
    * INTENDS TO USE NET PROCEEDS FROM RESERVED OFFERING TO ACTIVELY PREPARE
COMMERCIAL LAUNCH OF LUMEVOQ(®) IN EUROPE  urn:newsml:reuters.com:*:nFWN2HC0W9

Source text for Eikon:  ID:nBw7Ncy6ra 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))